Browse the corpus

Cherry hemangiomas are the most common type of acquired vascular proliferation of the skin. They present as a dome-shaped, bright, ruby-colored papule with a pale halo. This activity describes the evaluation and management of cherry hemangiomas and highlights the role of the interprofessional team in the care of patients with this condition. Objectives: Identify the histopathology of cherry hemangioma. Review the appropriate history, physical, and evaluation of cherry hemangioma. Outline the management options for cherry hemangioma. Summarize the importance of collaboration and communication within the interprofessional team to enhance the care of patients with cherry hemangioma. Access free multiple choice questions on this topic.

Cherry hemangiomas are common benign cutaneous vascular proliferations. They are also known as cherry angiomas, adult hemangiomas, or senile angiomas, as their number tends to increase with age.[1] They were named Campbell De Morgan spots after the surgeon who worked at Middlesex Hospital from 1842 to 1875.[2] See Image. Cherry Hemangioma. According to the current classification by the International Society for Vascular Anomalies (ISSVA) of benign vascular tumors, cherry hemangiomas are not included, despite their distinct clinical and histopathological features and high prevalence in adults.[1] In the international literature, Campbell De Morgan spots have variously been known as senile angiomas, angioma eruption, angioma tuberosum, senile ectasia, angioma nodulare cutis, perles sanguines, ruby spots, and cancerodermes. Although De Morgan (1811 to 1876) associated these spots with cancer, this finding is not common. According to light and electron microscopic studies of telangiectasia, cherry hemangiomas are a type of papular telangiectasia. These true capillary hemangiomas consist of newly formed capillaries with narrow lumens and prominent endothelial cells arranged in a lobular pattern in the papillary dermis.[3] Cherry hemangiomas generally appear as multiple, 1 mm to 5 mm, bright-red, dome-shaped papules, mostly on the trunk or upper limbs, and rarely on the hands, feet, or face.[3]

There is no well-known cause of cherry angiomas. Some of the associations and possible etiologies of these lesions are as follows. Aging: Since these lesions are most commonly seen in old age, the aging process may be a cause of their development.[3] Genetic mutation: Some studies have seen somatic missense mutations in GNAQ (Q209H, Q209R, R183G) and GNA11 (Q209H) genes in these lesions.[4] Pregnancy Eruptive cherry angiomas: This term indicates the sudden development of multiple and extensive cherry angiomas. They may be seen in the following conditions: A side effect of topical nitrogen mustard used for the treatment of vitiligo [5] A side effect of cyclosporine [6] Chronic graft-host disease [7] Lymphoproliferative diseases and multicentric Castleman disease (MCD): The possible mechanism is hypersecretion of vascular endothelial growth factor in response to elevated interleukin 6 levels. Therefore, it is suggested that if the patient presents with sudden multiple cherry angiomas along with systemic symptoms and lymphadenopathy, the patient should be evaluated for multicentric Castleman disease (MCD) and other lymphoproliferative disorders.[8] A side effect of ramucirumab: The underlying mechanism for this is ramucirumab-induced somatic activating VEGFR2 mutation.[9] Human herpesvirus-8 (HHV8): It is frequently found in eruptive cherry hemangiomas (52.9%)[10]

Cherry hemangiomas are seen in about 7% of adolescents and 75% of adults over 75 years of age.[2] These lesions develop in adults in the third or fourth decade of life. About 5% to 41% of people develop cherry hemangiomas in their 20s. These lesions begin as small red macules or papules. They are initially 1mm in size and can reach up to 2.3 mm by the age of 50 but are usually less than 3.5 mm.[2] Cherry hemangiomas are distributed equally in individuals of all races and ethnicities. They show no gender predisposition.

Cherry angiomas mostly appear with age. Although they are associated with some malignancies, they are most often found in healthy individuals. These lesions begin as bright red, flat macules and grow to become 1 to 5 mm red papules. They are usually asymptomatic but can bleed with trauma.[3] They can appear on both sun-exposed and unexposed skin, but usually spare mucous membranes. These lesions are present in the dermal papillae, and they consist of tortuous and spherical dilatations of capillary loops.[11] It has been noted that the color of the cherry angiomas changes with hypoxia; they become blue rather than red. The small spots are noted to turn blue sooner than the larger ones. Once the patient is restored to cardiovascular stability, the lesions revert to their ruddy red color.[12]

Histologic examination of these lesions shows that they are located immediately beneath the epidermis in the papillary dermis and have a distinct structure from that of surrounding tissues.[13] These are true capillary hemangiomas, composed of newly formed capillaries with narrow lumens, lined by prominent endothelial cells arranged in a lobular pattern.[3] The capillaries forming cherry hemangioma show perivascular hyalinized sheaths. On immunohistochemical staining, perivascular hyalinized sheath and intercapillary connective tissue of the hemangiomas show marked staining for type VI collagen.[14]

Cherry hemangiomas are dome-shaped, bright, ruby-colored papules with a pale halo. They are small, well-demarcated, and often separated by septa. They are usually 1 to 5 millimeters in diameter. They most often present as multiple lesions, usually on the trunk or proximal extremities. They are rarely seen on the face, hands, and feet. When found as multiple adjoining angiomas, they are said to form a polypoid angioma. These lesions most often blanch with applied pressure, but some are fibrotic and may not blanch completely.[15] These lesions are the most common type of acquired vascular proliferation of the skin. They are diagnosed clinically by appearance. These lesions have no malignant potential. Although they have no malignant potential, they may be confused with amelanotic melanoma, which, in contrast, is more friable.[4]

Cherry hemangiomas are diagnosed clinically by appearance. Optical coherence tomography, a low-energy light-based imaging device, can be used to evaluate cherry hemangiomas before laser therapy. This imaging study determines the extent and depth of these lesions, which are useful for predicting their response to laser therapy.[16] If there is a concern for malignancy, the lesion should be excised and sent for histopathologic examination.[4] Although cherry hemangiomas are diagnosed clinically by appearance, their histopathologic findings are essentially the same as those of true capillary hemangiomas.[3] These histopathologic findings include a thinned epidermis and many newly developed, polypoid, neovascularized capillaries. These capillaries have thin, narrow lumens along with prominent endothelial cells. The endothelial cells are most often arranged in a lobular fashion in the papillary dermis.[1] The newly formed capillaries are found early, while the capillaries dilate later. Therefore, late-stage tumors often tend to have increased dilated vessels.[3] The proliferative activation of endothelial cells may therefore be specific to the early stage and may disappear in the later stage.[1] In addition to these findings, collagen fibers between blood vessels appear homogeneous and exhibit edematous changes. The epidermis may be atrophic, as characterized by loss of rete ridges. The epidermal collarette resembles a pyogenic granuloma. In addition, immunohistochemical staining demonstrates no abnormality in the expression or distribution of alpha-smooth-muscle actin and type IV collagen on the capillaries of cherry hemangiomas that have undergone proliferation. The dilated and congested vessels demonstrated through immunohistochemical staining may be responsible for the bright ruby-red appearance of cherry hemangiomas.[3] The atrophic epidermis and proximity to the epidermis, also demonstrated through immunohistochemical staining, may be responsible for the ease of bleeding of these lesions secondary to trauma.

These lesions are most often asymptomatic but may bleed with trauma.[17] Patients may want to remove a cherry hemangioma, most often for either cosmetic reasons or for the prevention of bleeding following trauma.[18] Treatment for smaller lesions includes local anesthesia with 1% lidocaine, followed by electrocauterization. Larger lesions are often treated with shave excision, with electrocauterization of the base. In addition, cryotherapy may be employed. Superficial lesions may also be treated with CO2 laser therapy.[17] Although cryosurgery, electrosurgery, or curettage have traditionally been employed in the treatment of cherry hemangioma, more recently, pulsed dye laser or intense pulsed light has been used with success. Krypton and 532 nm diode lasers work very well in eradicating these lesions.[19] Patients should be advised that removal of these lesions may result in scarring.[18]

In addition to amelanotic melanoma, the differential diagnosis of cherry hemangioma includes lobular capillary hemangioma, pyogenic granuloma, acquired tufted hemangioma, glomeruloid hemangioma, targetoid hemosiderotic hemangioma, angiolymphoid hyperplasia with eosinophilia, and spindle cell hemangioma.[4]

These lesions may bleed with trauma.[17] Patients may want to remove a cherry hemangioma most often for either cosmetic reasons or for the prevention of bleeding following trauma.[18] Patients should be advised that removal of these lesions may result in scarring.[18]

Because cherry hemangioma is associated with certain chemicals, patients should be advised to avoid topical nitrogen mustard therapy, bromides, or other chemicals.[20] These are increasingly used in tropical climates. In addition, these lesions are often larger in patients with diabetes.[21] They are found with higher expansion rates in tropical climates. Cherry hemangiomas are often associated with liver transplants, graft versus host disease, and patients who are immunocompromised secondary to cyclosporine treatment. They may also be seen in patients with cerebral cavernous malformations. In addition, a case of familial nevus flammeus with early-onset cherry hemangiomas has been reported.[20] Cherry hemangiomas have been found in increasing numbers in middle-aged to older adults. The number of these lesions tends to increase with age. Most often, these lesions develop after the third decade of age. They are found in only 5% of adolescents, but 75% of adults over 75 years of age. In addition, multiple cherry hemangiomas have been reported in nursing home patients with a strong association with infections.[21]

Cherry hemangiomas are the most common type of acquired vascular proliferation of the skin and are diagnosed clinically by appearance.[4] The physical exam may demonstrate a well-demarcated, dome-shaped, bright, ruby-colored papule with a pale halo. If there is a concern for malignancy, the lesion must be excised and sent for histopathologic examination, involving coordination of care amongst providers. Once histopathologic findings return, demonstrating a thinned epidermis, newly developed, polypoid, neovascularized capillaries, coordination with further providers is warranted for excision.[1] Although these lesions are most often asymptomatic, they may bleed with trauma, and patients may want to remove the lesion for either cosmetic reasons or for the prevention of bleeding following trauma. The involvement of a provider capable of electrocauterization, shave excision, cryotherapy, CO2 laser therapy, curettage, pulsed dye laser therapy, or intense pulsed light therapy is warranted.[18] To optimize outcomes following the diagnosis of a cherry hemangioma, prompt coordination of an interprofessional team is recommended.